Saturday, December 29, 2007

TENS for Labor/Delivery

Tens is predominantly used in Europe, more so than in U.S., for labor and delivery pain. The patient often purchases a unit specific for the delivery process and is instructed prior to the need on how to use the unit.

Many years ago in the U.S. 3M company had a unit specific to the delivery process and integrated into it's design a "squeeze handle" which incresed the power when squeezed. This adaptation for this procedure was based upon most people tend to squeeze their hands when they experience pain and taking advantage of that response the patient would regulate the amount of stimulation concurrent with her degree of pain. Unfortunately in the U.S. labor pain is not regarded as "chronic" so the use of the unit was not covered and as with many innovations in the U.S. the unit soon was discontinued.

That is unfortunate as the units are totally safe, totally drug-free thusly leaving the patient in control and it does not affect the natural responses to childbirth ( other than pain reduction!!).

In the U.S. it is not unusual to see Physical Therapists use the units themselves for labor and delivery and also the units are very helpful for Caeserean section patients used post operatively.

Thursday, December 13, 2007

Ultraviolet Patent for Use With Dental Patients

MedFaxx's owner has filed for patent on use of similar V-254 Wound Lamp product to be used with dental procedures.

In dental procedures there is increased probability of systemic infections due to performing procedures that open up circulatory system to direct infections. The mouth is full of harmful bacteria and any opening of the gums and cirulatory system allows bacteria directly into blood system. With the advent of the MRSA and VRE bacteria and other advanced mutations the device takes aim at prevention of acqiring harmful bacteria in the dental office during routine procedures.

View patent.

For more information contact patent holder at 800-937-3993.

Tuesday, December 11, 2007

Interferential/Tens for Chronic Low Back Pain ( CLBP)

NIH report from NIH on use of above for rehab. and pain reduction using both forms of electrotherapy. Here is post.

Summary below:

Interferential and horizontal therapies in chronic low back pain: a randomized, double blind, clinical study.
Zambito A, Bianchini D, Gatti D, Viapiana O, Rossini M, Adami S.

Rheumatologic Rehabilitation, University of Verona, Italy.

OBJECTIVE: Chronic Low Back Pain (CLBP) is one of the most frequent medical problems. Electrical nerve stimulation is frequently used but its efficacy remains controversial. METHODS: Twenty-six men and 94 women with CLBP associated with either degenerative disk disease or previous multiple vertebral osteoporotic fractures were randomly assigned to either interferential currents (IFT), horizontal therapy (HT) or sham HT administered for 10, 40 and 40 minutes, respectively, daily for 5 days per week for two weeks together with a standard flexion-extension stretching exercise program, Blind efficacy assessment were obtained at baseline and at week 2, 6 and 14 and included a functional questionnaire (Backill), the standard visual analog scale (VAS) and the mean analgesic consumption. RESULTS: At week 2 a significant and similar improvement in both the VAS and Backill score was observed in all three groups. The Backill score continued to improve only in the two active groups with changes significantly greater than those observed in control patients at week 14. The pain VAS score returned to baseline values at week 6 and 14 in the control group while in the IFT and HT groups it continued to improve (p< 0.01 vs controls). The use of analgesic medications significantly improved at week 14 versus pretreatment assessment and over control patients only in the HT group. CONCLUSION: This randomized double-blind controlled study provides the first evidence that IFT and HT therapy are significantly effective in alleviating both pain and disability in patients with CLBP. The placebo effect is remarkable at the beginning of the treatment but it tends to vanish within a couple of weeks.

Friday, December 7, 2007

MedFaxx - Dedicated to Personal Service

We welcome your input or questions to us at MedFaxx. Our company has pioneered the use of interferential therapy for home visits as well as the use of the V-254 Wound Lamp for control of infectious agents such as MRSA and VRE.

We hold several patents in the above fields and understand the most powerful tool we can offer is to educate on the technologies. Please email or call us with questions you may have.